Difference between revisions of "Team:Paris Bettencourt/Project/VitaminB2"
Line 7: | Line 7: | ||
<div class="column-left" align="justify"> | <div class="column-left" align="justify"> | ||
<h1 class="date one" id="overview">Overview</h1> | <h1 class="date one" id="overview">Overview</h1> | ||
− | <p>Riboflavin derived coenzymes (FMN and FAD) are the cofactors of numerous oxydo-reduction enzymes and are also used in the energy transduction process. It is also used in antioxidative reactions and is required for the metabolism of several other vitamins | + | <p>Riboflavin derived coenzymes (FMN and FAD) are the cofactors of numerous oxydo-reduction enzymes and are also used in the energy transduction process. It is also used in antioxidative reactions and is required for the metabolism of several other vitamins.</p> |
− | + | ||
− | <p>Riboflavin deficiency is a rampant problem in India | + | <p>Riboflavin deficiency is a rampant problem in India. For socio-economic reasons, indians are not consuming riboflavin-rich food (dairy products, offal, eggs, almonds...). |
− | + | Only 13% of the households meet the riboflavin dietary requirements and more than 70% of women and children of low-income groups (2009 Indian Council of Medical Research report) and 66% of children from middle-income groups have biochemical evidence of riboflavin deficiency (S. Swaminathan & al., European J. Clin. Nut., 2013).<br> | |
Riboflavin deficiency is the cause of several diseases.</p> | Riboflavin deficiency is the cause of several diseases.</p> | ||
Revision as of 00:12, 18 September 2015